Innovent Biologics / Altruist Biologics

Exhibitors

Information

.

Contact details

United States

Products

Sessions

Unprecedented Post-Approval Production Cell Line Change of a Bevacizumab Biosimilar with the NMPA

Wednesday, October 25, 2023 12:45 PM to 1:15 PM
BioProduction Content - 3C49
Sun Chau Siu · Altruist Biologics

Team

Astrid MARIA Dahl
Astrid MARIA Dahl
Chief Operating Officer and Head (Europe)Innovent Biologics (Europe)
BB
Blake Blake.Salisbury
SVP of BDInnovent Biologics
Christina Li
Christina Li
Senior Manager Business Development, EuropeInnovent Biologics/Altruist Biologics
JG
Junhui Guo
BDInnovent Biologics
Kenneth Meek
Kenneth Meek
VP Business DevelopmentAltruist Biologics, Inc.

Log in

See all the content and easy-to-use features by logging in or registering!